Exclusive breastfeeding protects against postpartum migraine recurrence attacks?

Objectives: To observe postpartum migraine recurrence among migraine sufferers before pregnancy, its classifications and associated factors and to compare women, who were exclusively breastfeeding, with those that used other forms of infant feeding. Methods: Out of 686 consecutively assisted women, at the first postnatal week, 266 were identified as migraine sufferers before pregnancy. Among those, one in five that were exclusively breastfeeding (53) and all the ones consecutively using others forms of infant feeding (40) were interviewed at the first and forth postpartum weeks. Results: After multivariable analysis, exclusive breastfeeding, no breastfeeding problems, and low income were associated with decrease in migraine recurrence at the first postpartum week. At the fourth week, exclusive breastfeeding continued to be a protective factor. Conclusions: A decrease in postpartum migraine recurrence seems to be another advantage of exclusive breastfeeding

Consenso da Sociedade Brasileira de Cefaleia sobre o tratamento da migrânea crônica

Chronic migraine poses a significant personal, social and economic burden and is characterized by headache present on 15 or more days per month for at least three months, with at least eight days of migrainous headache per month. It is frequently associated with analgesic or acute migraine medication overuse and this should not be overlooked. The present consensus was elaborated upon by a group of members of the Brazilian Headache Society in order to describe current evidence and to provide recommendations related to chronic migraine pharmacological and nonpharmacological treatment. Withdrawal strategies in medication overuse headache are also described, as well as treatment risks during pregnancy and breastfeeding. Oral topiramate and onabotulinum toxin A injections are the only treatments granted Class A recommendation, while valproate, gabapentin, and tizanidine received Class B recommendation, along with acupuncture. biofeedback, and mindfulness. The anti-CGRP or anti-CGRPr monoclonal antibodies, still unavailable in Brazil, are promising new drugs already approved elsewhere for migraine prophylactic treatment, the efficacy of which in chronic migraine is still to be definitively proven777509520A migrânea (enxaqueca) crônica determina uma carga pessoal, social e econômica significativa e é caracterizada por dor de cabeça presente em quinze ou mais dias por mês por ao menos três meses, com no mínimo oito dias de cefaleia migranosa a cada mês. É frequentemente associada ao uso excessivo de medicação analgésica ou antimigranosa aguda e isso não deve ser negligenciado. Este consenso foi elaborado por um grupo de membros da Sociedade Brasileira de Cefaleia, para descrever as evidências atualmente disponíveis e fornecer recomendações relacionadas ao tratamento farmacológico e não farmacológico da migrânea crônica. Estratégias de retirada na cefaleia por uso excessivo de medicamentos também são descritas, assim como os riscos dos tratamentos durante a gravidez e a amamentação. O topiramato oral e as injeções de toxina onabotulínica A são os únicos tratamentos que receberam a recomendação classe A, enquanto que o valproato, a gabapentina e a tizanidina receberam recomendação classe B, juntamente com acupuntura, biofeedback e mindfulness. Os anticorpos monoclonais anti-CGRP ou anti-CGRPr, ainda não disponíveis no Brasil, são novos fármacos promissores, já aprovados em outros países para o tratamento profilático da migrânea, cuja eficácia na migrânea crônica ainda está por ser definitivamente comprovad

Craniovertebral junction malformation in Northeastern Brazil: the myth of the Dutch colonization

The high prevalence of craniovertebral junction malformation in Northeastern Brazil is historically associated with brachycephalic biotype (flat head), also common in this region. It has been postulated that this trait was introduced to this region by the Dutch during the colonial period in Brazil's history. Based on the confrontation of this paradigm against some historical facts, the authors concluded that the brachycephalic phenotype was inherited from prehistoric ancestors (Amerindians) who were already living in this region when white European men arrived

Mesial temporal lobe epilepsy: Clinical and neuropathologic findings of familial and sporadic forms

To evaluate the clinical and hippocampal histological features of patients with mesial temporal lobe epilepsy (MTLE) in both familial (FMTLE) and sporadic (SMTLE) forms. Patients with FMTLE (n = 20) and SMTLE (n = 39) who underwent surgical treatment for refractory seizures were studied at the University of Sao Paulo School of Medicine at Ribeirao Preto. FMTLE was defined when at least two individuals in a family had clinical diagnosis of MTLE. Hippocampi from all patients were processed for Nissl/HE and Timm's stainings. Both groups were compared for clinical variables, hippocampal cell densities, and intensity of supragranular mossy fiber staining. There were no significant differences between FMTLE and SMTLE groups in the following: age at the surgery, age of first usual epileptic seizure, history of initial precipitating injury (IPI), age of IPI, latent period, ictal and interictal video-EEG patterns, presence of hippocampal atrophy and signal changes at MRI, and postoperative outcome. In addition, no differences were found in cell densities in hippocampal cornu ammonis subfields (CA1, CA2, CA3, CA4), fascia dentata, polymorphic region, subiculum, prosubiculum, and presubiculum. However, patients with SMTLE had greater intensity of mossy fiber Timm's staining in the fascia dentata-inner molecular layer (p < 0.05). Patients with intractable FMTLE present a clinical profile and most histological findings comparable to patients with SMTLE. Interestingly, mossy fiber sprouting was less pronounced in patients with FMTLE, suggesting that, when compared to SMTLE, patients with FMTLE respond differently to plastic changes plausibly induced by cell loss, neuronal deafferentation, or epileptic seizures4961046105

Consenso latino-americano para as diretrizes de tratamento da migranea cronica

Chronic migraine is a condition with significant prevalence all around the world and high socioeconomic impact, and its handling has been challenging neurologists. Developments for understanding its mechanisms and associated conditions, as well as that of new therapies, have been quick and important, a fact which has motivated the Latin American and Brazilian Headache Societies to prepare the present consensus. The treatment of chronic migraine should always be preceded by a careful diagnosis review; the detection of possible worsening factors and associated conditions; the stratification of seriousness/impossibility to treat; and monitoring establishment, with a pain diary. The present consensus deals with pharmacological and nonpharmacological forms of treatment to be used in chronic migraine.A migrânea crônica é uma condição com prevalência significativa ao redor do mundo e alto impacto socioeconômico, sendo que seu manuseio tem desafiado os neurologistas. Os avanços na compreensão de seus mecanismos e das condições a ela associadas, bem como nas novas terapêuticas, têm sido rápidos e importantes, fato que motivou as Sociedades Latino-americana e Brasileira de Cefaleia a elaborarem o presente consenso. O tratamento da migrânea crônica deve ser sempre precedido por uma revisão cuidadosa do diagnóstico, pela detecção de possíveis fatores de piora e das condições associadas, pela estratificação de gravidade/impossibilidade de se tratar e pelo monitoramento com um diário da dor. Este consenso apresenta abordagens farmacológicas e não-farmacológicas para tratar a migrânea crônica.Universidad de Santiago de Chile and Sociedad de Neurologia Psiquiatria y NeurocirugiaUniversidad de Costa Rica Hospital San Juan de DiosUniversidade Federal de Minas Gerais Hospital das ClinicasUniversidade Jose do Rosario VellanoUniversidade de São Paulo Faculdade de Medicina Barao de Maua Faculdade de Medicina de Ribeirao PretoUniversidad Nacional de CordobaBrazilian and International Headache Societies Academia Brasileira de NeurologiaCentro Universitario de Volta Redonda Universidade Federal Fluminense (UFF)Universidad de la Republica Hospital Maciel Facultad de MedicinaUniversidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Sector of Investigation and Treatment of Headaches at Clinical Neurology in the Neurology DisciplineUniversidade Federal do Rio Grande do NorteUniversidade Federal do ParanaUFF Associacao Latino-Americana de CefaleiaUniversidade Estadual de Campinas Faculdade de Medicina de CatanduvaUSP Faculdade de Medicina de Ribeirao PretoUniversidade Federal de Ciencias da Saude de Porto Alegre Academia Brasileira de NeurologiaUniversidade de La SabanaUSP Faculdade de MedicinaHospital Perez CarrenoUFFUniversidad Mayor de San AndresUniversidad Central de Venezuela Hospital Vargas de CaracasUniversidade de Santo Amaro Escola Paulista de Medicina da UNIFESPUniversidad de GuadalajaraUNIFESP Universidade Federal de Santa CatarinaUSP Faculdade de Medicina de Ribeirao Preto Centro Educacional Barao de MauaUniversidade Federal de PernambucoUniversidad Mayor de San Andres Hospital das ClinicasAcademia Mexicana de Neurologia Hospital Especialidades Centro Medico La RazaSociedad NeurologicaHospital Israelita Albert Einstein UNIFESPUniversidad de ConcepcionUniversidade Federal do Rio de Janeiro Hospital Universitario Clementino Fraga Filho Faculdade de MedicinaUniversity of TrondheimASS Colombiana de Neurologia AHSUniversidad de Buenos AiresUniversidad Central de Venezuela Hospital VargasUniversidad Diego PortalesUniversidad de SantiagoInstituto de NeurologiaUFF Medicine SchoolUNIFESP, EPM, Sector of Investigation and Treatment of Headaches at Clinical Neurology in the Neurology DisciplineUniversidade de Santo Amaro Escola Paulista de Medicina da UNIFESP, Universidade Federal de Santa CatarinaHospital Israelita Albert Einstein UNIFESPSciEL

Consenso latino-americano para as diretrizes de tratamento da migranea cronica

Chronic migraine is a condition with significant prevalence all around the world and high socioeconomic impact, and its handling has been challenging neurologists. Developments for understanding its mechanisms and associated conditions, as well as that of new therapies, have been quick and important, a fact which has motivated the Latin American and Brazilian Headache Societies to prepare the present consensus. The treatment of chronic migraine should always be preceded by a careful diagnosis review; the detection of possible worsening factors and associated conditions; the stratification of seriousness/impossibility to treat; and monitoring establishment, with a pain diary. The present consensus deals with pharmacological and nonpharmacological forms of treatment to be used in chronic migraine.A migrânea crônica é uma condição com prevalência significativa ao redor do mundo e alto impacto socioeconômico, sendo que seu manuseio tem desafiado os neurologistas. Os avanços na compreensão de seus mecanismos e das condições a ela associadas, bem como nas novas terapêuticas, têm sido rápidos e importantes, fato que motivou as Sociedades Latino-americana e Brasileira de Cefaleia a elaborarem o presente consenso. O tratamento da migrânea crônica deve ser sempre precedido por uma revisão cuidadosa do diagnóstico, pela detecção de possíveis fatores de piora e das condições associadas, pela estratificação de gravidade/impossibilidade de se tratar e pelo monitoramento com um diário da dor. Este consenso apresenta abordagens farmacológicas e não-farmacológicas para tratar a migrânea crônica.47848

ATLANTIC MAMMAL TRAITS: a data set of morphological traits of mammals in the Atlantic Forest of South America

Univ Estadual Paulista, UNESP, Dept Ecol, Inst Biociencias, BR-13506900 Rio Claro, SP, BrazilUniv Fed Santa Catarina, Ctr Ciencias Biol, Dept Ecol & Zool, Florianopolis, SC, Brazil|Caipora Cooperat, Florianopolis, SC, BrazilUniv Estadual Santa Cruz, Programa Posgrad Ecol & Conservac Biodiversidade, Lab Ecol Aplicada Conservacao, Ilheus, BA, BrazilUniv Estadual Santa Cruz, CMARF, Ilheus, BA, BrazilUniv Brasilia, Dept Ecol, Inst Ciencias Biol, Lab Ecol Vertebrados, Brasilia, DF, BrazilUniv Fed Santa Maria, Dept Ecol & Evolut, Santa Maria, RS, BrazilUniv Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, SP, BrazilUniv Fed Espirito Santo, Ctr Ciencias Humanas & Nat, Dept Ciencias Biol, Vitoria, ES, BrazilUniv Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, BrazilUniv Fed Mato Grosso de Sul, Inst Biociencias, Campo Grande, MS, BrazilUniv Fed Parana, Dept Zool, Curitiba, Parana, BrazilUniv Fed Parana, Programa Posgrad Ecol & Conservcao, Curitiba, Parana, BrazilUniv Estado Rio de Janeiro, Dept Ecol, Rio De Janeiro, RJ, BrazilUniv Estadual Paulista, UNESP, Inst Biociencias, Dept Zool, Rio Claro, SP, BrazilUniv Extremo Sul Catarinense, Programa Posgrad Ciencias Ambientais, Criciuma, SC, BrazilUniv Sao Paulo, ESALQ, Dept Ciencias Biol, Piracicaba, SP, BrazilUniv Nacl Misiones, CONICET, Inst Biol Subtrop, Puerto Iguazu, Misiones, ArgentinaAsociac Civil Ctr Invest Bosque Atlantico, Puerto Iguazu, Misiones, ArgentinaFIOCRUZ Amazonas, Inst Leonidas & Maria Deane, Manaus, Amazonas, BrazilUniv Estadual Paulista, UNESP, Dept Zootecnia, Jaboticabal, SP, BrazilField Museum Nat Hist, Integrated Res Ctr, Chicago, IL 60605 USAUniv Fed Pernambuco, Ctr Biociencias, Dept Zool, Lab Ciencia Aplicada Conservacao Biodiversidade, Recife, PE, BrazilInst Chico Mendes Conservacao Biodiversidade, Ctr Nacl Pesquisa & Conservacao Mamiferos Carnivo, Sao Paulo, BrazilUniv Vale Rio dos Sinos, Sao Leopoldo, RS, BrazilUniv Reg Cariri, Dept Biol, Lab Ecol Mamiferos, Crato, CE, BrazilUniv Fed Rio de Janeiro, Dept Ecol, Lab Vertebrados, Rio De Janeiro, RJ, BrazilUniv Federal Mato Grosso do Sul, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, BrazilIPE, Nazare Paulista, SP, BrazilUniv Fed Minas Gerais, Programa Posgrad Zool, Belo Horizonte, MG, BrazilUniv Estado Minas Gerais, Dept Ciencias Biol, Ibirite, MG, BrazilPREA, Programa Educ Ambiental, Juiz De Fora, MG, BrazilChinese Acad Sci, Inst Zool, Key Lab Zool Systemat and Evolut, Beijing, Peoples R ChinaMinist Salud Nacion, Inst Nacl Med Trop INMeT, Puerto Iguazu, Misiones, ArgentinaUniv Fed Vicosa, Dept Engn Florestal, Vicosa, MG, BrazilUniv Fed Goias, Inst Biociencias, Jatai, Go, BrazilInst Chico Mendes Conservacao Biodiversidade ICMB, Ctr Nacl Pesquisa & Conservacao Primatas Brasilei, Joao Pessoa, PB, BrazilCtr Rescate Fauna Silvestre Guira Oga, Puerto Iguazu, ArgentinaFdn Hist Nat Felix de Azara, Buenos Aires, ArgentinaProjeto Carnivoros Iguacu, Foz Do Iguacu, PR, BrazilUniv Estadual Paulista, Dept Med Vet Prevent & Reprod Anim, Fac Ciencias Agr & Vet Jaboticabal, Jaboticabal, SP, BrazilUniv Fed Integracao Latinoamer, Inst Latinoamer Ciencias Vida & Nat, Foz Do Iguacu, PR, BrazilUniv Fed Sao Paulo, Dept Ciencias Ambientais, Diadema, SP, BrazilUniv Fed Paraiba, Dept Sistemat & Ecol, Lab Mamiferos, Joao Pessoa, Paraiba, BrazilIUCN Peccary Specialist Grp, Campo Grande, MS, BrazilWWF Brazil, Campo Grande, MS, BrazilChicago State Univ, Dept Biol Sci, Chicago, IL USAUniv Fed Rio de Janeiro, Nucleo Ecol & Desenvolvimento Socioambiental Maca, Macae, RJ, BrazilUniv Vila Velha, Programa Posgrad Ecol Ecossistemas, Vila Velha, ES, BrazilUniv Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Rio De Janeiro, RJ, BrazilUniv Fed Bahia, Programa Posgrad Ecol, Salvador, BA, BrazilUniv Fed Paraiba, Dept Sistemat & Ecol, Programa Posgrad Ciencias Biol Zool, Lab Mamiferos, Joao Pessoa, Paraiba, BrazilUniv Fed Sao Paulo, Dept Ciencias Ambientais, Diadema, SP, BrazilWeb of Scienc